Home > Insider Trading > Filing (0000899243-18-026075)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1655759	Arvinas Inc.	ARVN	Pharmaceutical Preparations (2834)	472566120

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753537	G John Houston	C/O Arvinas, Inc. 5 Science Park, 395 Winchester Ave. New Haven CT 06511	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-01	30,000	$16.00	772,860	No	4	P	Direct
Common Stock	Acquisiton	2018-10-01	12,484	$0.00	785,344	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2018-10-01	40,573	$0.00	12,484	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering.
On October 1, 2018, the Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.